Safety and Efficacy of GS-4774 in Patients with Chronic Hepatitis B on Oral Antiviral Therapy

被引：0

作者：

Lok, Anna S. ^{[1
]}

Pan, Calvin Q. ^{[2
]}

Han, Steven-Huy B. ^{[3
]}

Trinh, Huy N. ^{[4
]}

Fessel, Jeffrey ^{[5
]}

Rodell, Tim ^{[6
]}

Massetto, Benedetta ^{[7
]}

Nguyen, Anh-Hoa ^{[7
]}

Gaggar, Anuj ^{[7
]}

Subramanian, Mani ^{[7
]}

McHutchison, John G. ^{[7
]}

Ferrari, Carlo ^{[8
]}

Lee, Hannah ^{[9
]}

Gordon, Stuart C. ^{[10
]}

Gane, Edward J. ^{[11
]}

机构：

[1] Univ Michigan Hlth Syst, Ann Arbor, MI USA

[2] Med Procare PLLC, Flushing, NY USA

[3] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA

[4] San Jose Gastroenterol, San Jose, CA USA

[5] Kaiser Permanente, San Francisco, CA USA

[6] Globeimmune, Louisville, CO USA

[7] Gilead Sci Inc, Foster City, CA 94404 USA

[8] Univ Parma, I-43100 Parma, Italy

[9] Tufts Med Ctr, Boston, MA USA

[10] Henry Ford Hosp, Detroit, MI 48202 USA

[11] Auckland Gen Hosp, Auckland, New Zealand

来源：

HEPATOLOGY | 2015年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2015

引用

页码：1191A / 1191A

页数：1

共 50 条

[1] Safety and Efficacy of GS-4774 in combination with TDF in Patients with Chronic Hepatitis B not on Antiviral Medication
Janssen, Harry L.
Yoon, Seung Kew
Yoshida, Eric M.
Trinh, Huy N.
Rodell, Timothy C.
Anh-Hoa Nguyen
Gaggar, Anuj
Subramanian, Mani
Fung, Scott
Ahn, Sang Hoon
Ferrari, Carlo
Ma, Xiaoli
Mangia, Alessandra
HEPATOLOGY, 2016, 64 : 122A - 122A
[2] Therapy with GS-4774 and Tenofovir: Effects on T-Cells in chron. Hepatitis B
Gappa, Birgit
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (07): : 822 - +
[3] Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B
Lok, Anna S.
Pan, Calvin Q.
Han, Steven-Huy B.
Trinh, Huy N.
Fessel, W. Jeffrey
Rodell, Timothy
Massetto, Benedetta
Lin, Lanjia
Gaggar, Anuj
Subramanian, G. Mani
McHutchison, John G.
Ferrari, Carlo
Lee, Hannah
Gordon, Stuart C.
Gane, Edward J.
JOURNAL OF HEPATOLOGY, 2016, 65 (03) : 509 - 516
[4] Combined GS-4774 and tenofovir therapy can improve HBV-specific T cell responses in patients with chronic active hepatitis B
Boni, C.
Rossi, M.
Vecchi, A.
Laccabue, D.
Giuberti, T.
Alfieri, A.
Andreone, P.
Cursaro, C.
Margotti, M.
Mangia, A.
Santoro, R.
Piazzolla, V.
Brunetto, M. R.
Coco, B.
Cavallone, D.
Lau, A.
Gaggar, A.
Ferrari, C.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S29 - S29
[5] Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis
Boni, Carolina
Janssen, Harry L. A.
Rossi, Marzia
Yoon, Seung Kew
Vecchi, Andrea
Barili, Valeria
Yoshida, Eric M.
Trinh, Huy
Rodell, Timothy C.
Laccabue, Diletta
Alfieri, Arianna
Brillo, Federica
Fisicaro, Paola
Acerbi, Greta
Pedrazzi, Giuseppe
Andreone, Pietro
Cursaro, Carmela
Margotti, Marzia
Santoro, Rosanna
Piazzolla, Valeria
Brunetto, Maurizia R.
Coco, Barbara
Cavallone, Daniela
Zhao, Yang
Joshi, Adarsh
Woo, Jacky
Lau, Audrey H.
Gaggar, Anuj
Subramanian, G. Mani
Massetto, Benedetta
Fung, Scott
Ahn, Sang Hoon
Ma, Xiaoli
Mangia, Alessandra
Ferrari, Carlo
GASTROENTEROLOGY, 2019, 157 (01) : 227 - +
[6] Biologic Responses to GS-4774 in Virally-Suppressed Chronic HBV Patients
Ferrari, Carlo
Gane, Edward J.
Han, Steven-Huy B.
Fessel, W. Jeffrey
Trinh, Huy N.
Rodell, Tim
Gaggar, Anuj
Massetto, Benedetta
Podlaha, Ondrej
Johnson, Ann D.
Peiser, Leanne
Woo, Jacky
Subramanian, Mani
McHutchison, John G.
Gordon, Stuart C.
Pan, Calvin Q.
Lee, Hannah
Lok, Anna S.
HEPATOLOGY, 2015, 62 : 1209A - 1209A
[7] Current antiviral therapy of chronic hepatitis B: Efficacy and safety
Lam Y.-F.
Yuen M.-F.
Seto W.-K.
Lai C.-L.
Current Hepatitis Reports, 2011, 10 (4) : 235 - 243
[8] Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study
Gaggar, Anuj
Coeshott, Claire
Apelian, David
Rodell, Timothy
Armstrong, Brian R.
Shen, Gong
Subramanian, G. Mani
McHutchison, John G.
VACCINE, 2014, 32 (39) : 4925 - 4931
[9] A phase1 study evaluating anti-PD-1 treatment with or without GS-4774 in HBeAg negative chronic hepatitis B patients
Gane, E.
Gaggar, A.
Nguyen, A. H.
Subramanian, G. M.
McHutchison, J. G.
Schwabe, C.
Dunbar, R.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S26 - S27
[10] Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment
Agarwal, K.
Ahn, S. H.
Elkhashab, M.
Lau, A. H.
Gaggar, A.
Bulusu, A.
Tian, X.
Cathcart, A. L.
Woo, J.
Subramanian, G. M.
Andreone, P.
Kim, H. J.
Chuang, W. L.
Nguyen, M. H.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 (11) : 1331 - 1340

← 1 2 3 4 5 →